CorMedix

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CorMedix and other ETFs, options, and stocks.

About CRMD

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E.

CEO

Joseph Todisco

CEOJoseph Todisco

Employees

191

Employees191

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

2006

Founded2006

Employees

191

Employees191

CRMD Key Statistics

Market cap

362.44M

Market cap362.44M

Price-Earnings ratio

7.08

Price-Earnings ratio7.08

Dividend yield

—

Dividend yield—

Average volume

2.31M

Average volume2.31M

High today

$5.06

High today$5.06

Low today

$4.65

Low today$4.65

Open price

$4.87

Open price$4.87

Volume

2.39M

Volume2.39M

52 Week high

$13.02

52 Week high$13.02

52 Week low

$4.65

52 Week low$4.65

Stock Snapshot

CorMedix(CRMD) stock is priced at $4.71, giving the company a market capitalization of 362.44M. It carries a P/E multiple of 7.08.

On 2026-11-14, CorMedix(CRMD) stock moved within a range of $4.65 to $5.06. With shares now at $4.71, the stock is trading +1.3% above its intraday low and -6.8% below the session's peak.

Trading activity shows a volume of 2.39M, compared to an average daily volume of 2.31M.

The stock's 52-week range extends from a low of $4.65 to a high of $13.02.

CRMD News

TipRanks 2d

Heron’s 18.3% Stake in Cormedix Raises Governance Risks and Potential Valuation Overhang

Cormedix Inc. (CRMD) has disclosed a new risk, in the Share Price & Shareholder Rights category. Following the acquisition, he notes that Heron stockholders wi...

Benzinga 2d

Cormedix Q3 2026 Earnings Call Transcript - Benzinga

...

TipRanks 2d

CorMedix reports Q3 EPS (19c) vs. $1.26 last year

Reports Q3 revenue $54.52M, consensus $52.77M. Joseph Todisco, Chairman & Chief Executive Officer of CorMedix (CRMD), commented, “CorMedix will be entering 2027...

More CRMD News

Zacks 4d

Kura Oncology Reports Q3 Loss, Beats Revenue Estimates

Kura Oncology (KURA Quick QuoteKURA - Free Report) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.8...

TipRanks 5d

CorMedix to acquire Heron Therapeutics for $145M in cash upfront

CorMedix (CRMD) and Heron Therapeutics (HRTX) announced that they have entered into a definitive asset purchase agreement under which CorMedix will acquire subs...

People also own

Based on the portfolios of people who own CRMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.